61 related articles for article (PubMed ID: 1335277)
1. Quantitative structure-activity relationship studies on benzodiazepine receptor binding: recognition of active sites in receptor and modelling of interaction.
Gupta SP; Saha RN; Mulchandani V
J Mol Recognit; 1992 Jun; 5(2):75-80. PubMed ID: 1335277
[TBL] [Abstract][Full Text] [Related]
2. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM
Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057
[TBL] [Abstract][Full Text] [Related]
3. Quantitative structure-activity relationship studies on benzodiazepine receptor binding: investigation of interaction model.
Gupta SP; Mulchandani V
Indian J Biochem Biophys; 1993 Jun; 30(3):181-6. PubMed ID: 8406550
[TBL] [Abstract][Full Text] [Related]
4. Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligands.
Borea PA; Gilli G; Bertolasi V; Ferretti V
Mol Pharmacol; 1987 Apr; 31(4):334-44. PubMed ID: 3033465
[TBL] [Abstract][Full Text] [Related]
5. Quantitative structure-activity relationship study of some benzodiazepine-receptor ligands having inverse agonist/antagonist and agonist actions.
Sharma RC; Ojha TN; Tiwari S; Singh P
Drug Des Discov; 1992; 9(2):135-43. PubMed ID: 1338366
[TBL] [Abstract][Full Text] [Related]
6. Comparative quantitative structure-activity relationship studies (QSAR) on non-benzodiazepine compounds binding to benzodiazepine receptor (BzR).
Hadjipavlou-Litina D; Garg R; Hansch C
Chem Rev; 2004 Sep; 104(9):3751-94. PubMed ID: 15352779
[No Abstract] [Full Text] [Related]
7. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis.
Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM
J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648
[TBL] [Abstract][Full Text] [Related]
8. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor.
Kahnberg P; Howard MH; Liljefors T; Nielsen M; Nielsen EØ; Sterner O; Pettersson I
J Mol Graph Model; 2004 Dec; 23(3):253-61. PubMed ID: 15530821
[TBL] [Abstract][Full Text] [Related]
9. The nature of 1,4-benzodiazepines/receptor interactions.
Borea PA; Gilli G
Arzneimittelforschung; 1984; 34(6):649-52. PubMed ID: 6091702
[TBL] [Abstract][Full Text] [Related]
10. Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC.
Ghose AK; Crippen GM
Mol Pharmacol; 1990 May; 37(5):725-34. PubMed ID: 2160062
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine/barbiturate/GABA receptor-chloride ionophore complex in a genetic model for generalized epilepsy.
Olsen RW; Wamsley JK; Lee RJ; Lomax P
Adv Neurol; 1986; 44():365-78. PubMed ID: 3010677
[TBL] [Abstract][Full Text] [Related]
12. Pseudoreceptor models and 3D-QSAR for imidazobenzodiazepines at GABA A/BzR subtypes alphaxbeta3gamma2 [x = 1-3, 5, and 6] via flexible atom receptor model.
Lu A; Zhou J
J Chem Inf Comput Sci; 2004; 44(3):1130-6. PubMed ID: 15154782
[TBL] [Abstract][Full Text] [Related]
13. 3D-pharmacophores of flavonoid binding at the benzodiazepine GABA(A) receptor site using 4D-QSAR analysis.
Hong X; Hopfinger AJ
J Chem Inf Comput Sci; 2003; 43(1):324-36. PubMed ID: 12546568
[TBL] [Abstract][Full Text] [Related]
14. The benzodiazepine/alcohol antagonist Ro 15-4513: binding to a GABAA receptor subtype that is insensitive to diazepam.
Turner DM; Sapp DW; Olsen RW
J Pharmacol Exp Ther; 1991 Jun; 257(3):1236-42. PubMed ID: 1646328
[TBL] [Abstract][Full Text] [Related]
15. Theoretical structure-activity studies of benzodiazepine analogues. Requirements for receptor affinity and activity.
Loew GH; Nienow JR; Poulsen M
Mol Pharmacol; 1984 Jul; 26(1):19-34. PubMed ID: 6087115
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the relative in vitro and in vivo binding affinities of various benzodiazepines and related compounds for the benzodiazepine receptor and for the peripheral benzodiazepine binding site.
Groh B; Müller WE
Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):463-6. PubMed ID: 2997890
[No Abstract] [Full Text] [Related]
17. Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment.
Smith TA
Br J Biomed Sci; 2001; 58(2):111-21. PubMed ID: 11440203
[TBL] [Abstract][Full Text] [Related]
18. The involvement of the benzodiazepine receptor in hepatic encephalopathy: evidence for the presence of a benzodiazepine receptor ligand.
Basile AS; Ostrowski NL; Gammal SH; Jones EA; Skolnick P
Adv Biochem Psychopharmacol; 1990; 46():189-200. PubMed ID: 1963266
[TBL] [Abstract][Full Text] [Related]
19. Affinity of 3-acyl substituted 4-quinolones at the benzodiazepine site of GABA(A) receptors.
Lager E; Nilsson J; Østergaard Nielsen E; Nielsen M; Liljefors T; Sterner O
Bioorg Med Chem; 2008 Jul; 16(14):6936-48. PubMed ID: 18541432
[TBL] [Abstract][Full Text] [Related]
20. Oxadiazolylimidazobenzodiazepines as novel partial agonists with the benzodiazepine receptor: a QSAR analysis.
Sharma RC; Singh P; Ojha TN
Res Commun Chem Pathol Pharmacol; 1993 Jun; 80(3):357-62. PubMed ID: 8394598
[No Abstract] [Full Text] [Related]
[Next] [New Search]
